Trial Details
Not RecruitingBasic Information
| Clinical ID | c2414 |
|---|---|
| Identifier | EUCTR2021-000570-28-FI |
| Trial Title | Accelerated infliximab infusions in inflammatory bowel disease, Phase IV trial - Accelerated IFX infusions in IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel diseases;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Zessly, Remsima, Remicade Product Name: infliximab Pharmaceutical Form: Infusion INN or Proposed INN: INFLIXIMAB CAS Number: 170277-31-3 |
Participant Information
| Sponsor | Tampere University Hospital |
|---|---|
| City | - |
| Country/Region | Finland |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |